Alleles
Biomarkers, Tumor
Cohort Studies
Female
Genetic Association Studies
Genetic Predisposition to Disease
Genetic Testing
Genetic Variation
Genotype
Germ-Line Mutation
Hereditary Breast and Ovarian Cancer Syndrome
/ epidemiology
Humans
Phenotype
Population Surveillance
Spain
/ epidemiology
Triple Negative Breast Neoplasms
/ epidemiology
Tumor Suppressor Proteins
/ genetics
Ubiquitin-Protein Ligases
/ genetics
BARD1
breast cancer
hereditary breast and ovarian cancer
moderate cancer risk
ovarian cancer
triple-negative breast cancer
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
23 01 2021
23 01 2021
Historique:
received:
18
12
2020
revised:
13
01
2021
accepted:
20
01
2021
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
27
7
2021
Statut:
epublish
Résumé
Only a small fraction of hereditary breast and/or ovarian cancer (HBOC) cases are caused by germline variants in the high-penetrance breast cancer 1 and 2 genes (
Identifiants
pubmed: 33498765
pii: genes12020150
doi: 10.3390/genes12020150
pmc: PMC7911518
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Tumor Suppressor Proteins
0
BARD1 protein, human
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Cancer Res Clin Oncol. 2018 Dec;144(12):2495-2513
pubmed: 30306255
J Mol Diagn. 2020 Apr;22(4):544-554
pubmed: 32068069
Genes (Basel). 2020 Jul 27;11(8):
pubmed: 32726901
Clin Genet. 2016 Mar;89(3):336-40
pubmed: 26010302
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):359-367
pubmed: 31871109
Sci Rep. 2017 Jan 04;7:37984
pubmed: 28050010
Int J Cancer. 2019 Nov 15;145(10):2682-2691
pubmed: 30927264
NPJ Breast Cancer. 2020 Jun 12;6:25
pubmed: 32566746
J Natl Cancer Inst. 2015 Aug 27;107(11):
pubmed: 26315354
Cancer. 2015 Jan 1;121(1):25-33
pubmed: 25186627
BMJ Open. 2018 Mar 27;8(3):e018324
pubmed: 29593016
J Biol Chem. 2008 Jul 25;283(30):21179-86
pubmed: 18480049
Cancer. 2017 May 15;123(10):1721-1730
pubmed: 28085182
JAMA Oncol. 2019 Jan 1;5(1):51-57
pubmed: 30128536
J Natl Cancer Inst. 2018 Aug 1;110(8):855-862
pubmed: 30099541
Gynecol Oncol. 2017 Nov;147(2):375-380
pubmed: 28888541
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Breast Cancer Res Treat. 2016 Apr;156(3):507-515
pubmed: 27083178
Oncogene. 2005 May 26;24(23):3726-36
pubmed: 15782130
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Biochemistry. 2007 Jul 3;46(26):7706-12
pubmed: 17550235
Breast Cancer Res Treat. 2020 Jun;181(2):465-473
pubmed: 32318955
Gynecol Oncol. 2018 Dec;151(3):481-488
pubmed: 30322717
JAMA Oncol. 2017 Sep 1;3(9):1190-1196
pubmed: 28418444
Eur J Hum Genet. 2020 Dec;28(12):1645-1655
pubmed: 32561899
Sci Rep. 2017 Jan 04;7:39348
pubmed: 28051113
Breast Cancer Res. 2019 Apr 29;21(1):55
pubmed: 31036035
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Mol Cell. 1999 Oct;4(4):511-8
pubmed: 10549283
Genet Med. 2018 Dec;20(12):1677-1686
pubmed: 29988077
Wellcome Open Res. 2016 Nov 25;1:20
pubmed: 28459104
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
Hum Mutat. 2010 Mar;31(3):E1175-85
pubmed: 20077502
NPJ Breast Cancer. 2017 Jun 9;3:22
pubmed: 28649662
J Clin Oncol. 2015 Feb 1;33(4):304-11
pubmed: 25452441
J Biol Chem. 2001 May 4;276(18):14537-40
pubmed: 11278247
Genes (Basel). 2020 Jul 15;11(7):
pubmed: 32679805